Inactive Ingredient Search for Approved Drug Products

Latest News: FDA announced upcoming changes to the Inactive Ingredient Database: more information


Search Names Beginning with K

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Record Updated
KAOLIN ORAL CAPSULE 1332587 24H4NWX5CO NA
KAOLIN ORAL CAPSULE, COATED PELLETS 1332587 24H4NWX5CO 14.61mg
KAOLIN ORAL CAPSULE, EXTENDED RELEASE 1332587 24H4NWX5CO 21mg
KAOLIN ORAL POWDER, FOR SUSPENSION 1332587 24H4NWX5CO NA
KAOLIN ORAL SYRUP 1332587 24H4NWX5CO 10mg/1ml
KAOLIN ORAL TABLET 1332587 24H4NWX5CO 150mg
KAOLIN ORAL TABLET, COATED 1332587 24H4NWX5CO 52.44mg
KAOLIN ORAL TABLET, DELAYED RELEASE 1332587 24H4NWX5CO 18.5mg
KAOLIN ORAL TABLET, EXTENDED RELEASE 1332587 24H4NWX5CO 66mg
KAOLIN ORAL TABLET, SUGAR COATED 1332587 24H4NWX5CO NA
KAOLIN TOPICAL PATCH 1332587 24H4NWX5CO 0.03mg/mg
KAOLIN TOPICAL PATCH, EXTENDED RELEASE 1332587 24H4NWX5CO 0.03mg/mg
KOLLIDON SR ORAL TABLET, EXTENDED RELEASE 26487668 S34RY76LK6 371.25mg

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 5, 2019
Database Last Updated: July 24, 2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English